These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26999003)

  • 1. The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α.
    Ali HO; Arroyo AB; González-Conejero R; Stavik B; Iversen N; Sandset PM; Martínez C; Skretting G
    J Thromb Haemost; 2016 Jun; 14(6):1226-37. PubMed ID: 26999003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens.
    B Arroyo A; Salloum-Asfar S; Pérez-Sánchez C; Teruel-Montoya R; Navarro S; García-Barberá N; Luengo-Gil G; Roldán V; Hansen JB; López-Pedrera C; Vicente V; González-Conejero R; Martínez C
    Sci Rep; 2017 Feb; 7():43500. PubMed ID: 28240250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-ribonucleic Acid 494 regulation of protein S expression.
    Tay JW; Romeo G; Hughes QW; Baker RI
    J Thromb Haemost; 2013 Aug; 11(8):1547-55. PubMed ID: 23789915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen induced downregulation of TFPI expression is mediated by ERα.
    Ali HO; Stavik B; Dørum E; Iversen N; Sandset PM; Skretting G
    Thromb Res; 2014 Jul; 134(1):138-43. PubMed ID: 24785473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region.
    Ali HO; Stavik B; Myklebust CF; Andersen E; Dahm AE; Iversen N; Sandset PM; Skretting G
    PLoS One; 2016; 11(3):e0152114. PubMed ID: 26999742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low abundance of TFPI-2 by both promoter methylation and miR-27a-3p regulation is linked with poor clinical outcome in gastric cancer.
    Geng G; Liu X; Xu A; Lu Z; Chen K; He J; Qi D; Yuan X
    J Gene Med; 2020 May; 22(5):e3166. PubMed ID: 31984574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7.
    Zhao W; Zhang X; Liu J; Sun B; Tang H; Zhang H
    Oncol Rep; 2016 Dec; 36(6):3691-3699. PubMed ID: 27779715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1.
    Dahm AE; Iversen N; Birkenes B; Ree AH; Sandset PM
    BMC Cardiovasc Disord; 2006 Oct; 6():40. PubMed ID: 17029634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
    Ljepoja B; García-Roman J; Sommer AK; Wagner E; Roidl A
    Breast; 2019 Feb; 43():31-38. PubMed ID: 30415143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples.
    Xiong J; Yu D; Wei N; Fu H; Cai T; Huang Y; Wu C; Zheng X; Du Q; Lin D; Liang Z
    FEBS J; 2010 Apr; 277(7):1684-94. PubMed ID: 20180843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen induced expression of tissue factor pathway inhibitor-2 in MCF7 cells involves lysine-specific demethylase 1.
    Andresen MS; Ali HO; Myklebust CF; Sandset PM; Stavik B; Iversen N; Skretting G
    Mol Cell Endocrinol; 2017 Mar; 443():80-88. PubMed ID: 28088469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
    Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.
    Cui XY; Tinholt M; Stavik B; Dahm AE; Kanse S; Jin Y; Seidl S; Sahlberg KK; Iversen N; Skretting G; Sandset PM
    J Thromb Haemost; 2016 Feb; 14(2):387-96. PubMed ID: 26598923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells.
    Stavik B; Skretting G; Olstad OK; Sletten M; Dehli Vigeland M; Sandset PM; Iversen N
    PLoS One; 2012; 7(10):e47184. PubMed ID: 23071754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
    Li X; Mertens-Talcott SU; Zhang S; Kim K; Ball J; Safe S
    Endocrinology; 2010 Jun; 151(6):2462-73. PubMed ID: 20382698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
    Han L; Liu B; Jiang L; Liu J; Han S
    Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
    Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D
    BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
    Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
    Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancer.
    Cai B; Chen W; Pan Y; Chen H; Zhang Y; Weng Z; Li Y
    Prostate; 2017 Jul; 77(10):1057-1065. PubMed ID: 28631332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.